Solventum Corp reported $1.1B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Abbott USD 5.86B 675M Mar/2026
Align Technology USD 736.59M 53M Mar/2026
Baxter International USD 891M 314M Mar/2026
Becton, Dickinson and Co. USD 2.15B 257M Mar/2026
Cencora USD 2.99B 31.87M Dec/2025
Dexcom USD 750.3M 42.4M Mar/2026
Insulet USD 540.8M 27.8M Mar/2026
Solventum Corp USD 1.1B 70M Mar/2026
West Pharmaceutical Services USD 296.4M 7.5M Mar/2026
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025